Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
long intergenic non-protein coding RNA 313 (LINC00313)
- Target
- LINC00313
- Molecular classification
- Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)[5][9]
01
Overview
Long intergenic non-protein coding RNA 313 (LINC00313) is a member of the lincRNA family, defined as a long non-coding RNA transcribed from intergenic regions and not overlapping with annotated protein-coding genes[9][6]. These transcripts are usually spliced, capped, and polyadenylated, and while some lincRNAs have been shown to play important biological roles, most—including LINC00313—are not yet functionally characterized[7][9]. LincRNAs generally function in regulation of gene expression at multiple levels (chromatin modification, transcriptional control, post-transcriptional modulation) and may act as molecular scaffolds, sponges, or decoys for other RNAs or proteins[1][5][9]. LINC00313 is annotated on chromosome 21, has no reported protein-coding potential, and is not currently classified as a direct therapeutic target, biomarker, or disease gene.
- Other names
- C21ORF84NCRNA00313[7]
02
Biological functions
Unknown/specific functions uncharacterized for LINC00313General lincRNA functions: chromatin remodeling, regulation of gene expression, potential roles as RNA scaffolds or decoys, fine-tuning of nearby gene expression[9][2][1]
03
Disease associations
Unknown/specific disease associations for LINC00313 have not been established in current literaturelincRNAs in general: various types may be implicated in cancer, neurodegeneration, inflammation, autoimmune diseases[5]
Beyond the preview
Go deeper on long intergenic non-protein coding RNA 313 (LINC00313).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on long intergenic non-protein coding RNA 313 (LINC00313).